Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Genetic testing may minimise liver injury risk for lumiracoxib

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Paulding CA, Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, Wright TM, Meyer J.HLA alleles associated with lumiracoxib-related liver injury may increase the safety profile of lumiracoxib. 11th Annual Congress of the European League Against Rheumatism: abstr. THU0031, 16 Jun 2010. Available from: URL: http://www.eular.org

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Genetic testing may minimise liver injury risk for lumiracoxib. React. Wkly. 1308, 7 (2010). https://doi.org/10.2165/00128415-201013080-00011

    Download citation

    Keywords

    • Public Health
    • Genetic Testing
    • Genetic Marker
    • Liver Injury
    • Liver Enzyme